Corcept Therapeutics
CORT
#2078
Rank
C$12.53 B
Marketcap
C$118.95
Share price
1.71%
Change (1 day)
42.77%
Change (1 year)

Revenue for Corcept Therapeutics (CORT)

Revenue in 2025 (TTM): C$1.04 Billion

According to Corcept Therapeutics 's latest financial reports the company's current revenue (TTM ) is C$1.02 Billion. In 2024 the company made a revenue of C$0.96 Billion an increase over the revenue in the year 2023 that were of C$0.63 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Corcept Therapeutics from 2009 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) C$1.04 B7.46%
2024 C$0.96 B51.4%
2023 C$0.63 B17.33%
2022 C$0.54 B16.91%
2021 C$0.46 B3.37%
2020 C$0.45 B12.72%
2019 C$0.40 B16.96%
2018 C$0.34 B70.99%
2017 C$0.20 B83.15%
2016 C$0.10 B56.67%
2015 C$69.75 M126.39%
2014 C$30.81 M179.48%
2013 C$11.02 M235.26%
2012 C$3.28 M
2011 N/A
2010 N/A-100%
2009 C$0.03 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Johnson & Johnson
JNJ
C$127.30 B 12,332.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$66.35 B 6,380.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$77.87 B 7,505.79%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
C$82.08 B 7,917.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$86.73 B 8,371.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$88.74 B 8,566.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
C$0.41 B-59.01%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
C$0.43 B-57.66%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
C$4.27 B 317.45%๐Ÿ‡บ๐Ÿ‡ธ USA